NHS Glasgow Rolls Out Miscarriage Cradle
Analysis based on 6 articles · First reported Mar 25, 2026 · Last updated Mar 25, 2026
The rollout of the miscarriage collection cradle by United Kingdom — NHS Greater Glasgow and Clyde, supported by Dignity Care, is expected to improve patient care and potentially reduce healthcare costs by freeing up surgery slots. This innovation could lead to increased investment and adoption of similar medical devices in the healthcare sector, positively impacting companies like Dignity Care.
United Kingdom — NHS Greater Glasgow and Clyde is becoming the first health board in the United Kingdom to fully roll out an innovative medical device called the miscarriage collection cradle. Designed by Dignity Care, this device offers women experiencing miscarriage a respectful way to manage their loss at home or in hospital, providing an alternative to surgery. It also helps preserve pregnancy tissue for genetic testing, which can offer insights into the cause of miscarriage. The initiative is supported by £1.5 million in funding from the Scotland — Scottish Government and is expected to save between £6.7 million and £11.2 million annually by reducing the need for surgery. Laura Corcoran, founder of Dignity Care, was inspired to create the device after her own experience with pregnancy loss. The rollout will begin at the Royal Alexandra Hospital and expand to other sites, including the Queen Elizabeth University Hospital and Princess Royal Maternity Hospital.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard